Segmed | De-identified Medical Imaging Data for AI & Clinical Research
Segmed | De-identified Medical Imaging Data for AI & Clinical Research 图标

Segmed | De-identified Medical Imaging Data for AI & Clinical Research

segmed.ai

Unlock Faster Healthcare Innovation: Access High-Quality, De-Identified Medical Imaging Data for AI & Research. Explore Now!

收录于 1 年前更新于 1 年前正常收录
Segmed | De-identified Medical Imaging Data for AI & Clinical Research 网站预览

详细内容

Close\
\
Close

Real-World Imaging Data for Health Innovation

About Segmed

Segmed provides at-scale access to novel clinical data globally, offering millions of

diagnostic-grade medical images to accelerate innovation and mature the evidence

needs of life sciences and technology industry.\
\
‍

Openda \
\
Get to know our proprietary data platform\
\

Healthcare Providers \
\
Join our global network of healthcare partners\
\

Explore Our Solutions \
\
Tailored for the needs of healthcare innovators\
\

RSNA 2025 \
\
Join Segmed activities in Chicago, from Nov 30 to Dec 3, 2025\
\

Solutions

We serve the pharmaceutical, medical devices and technology industries in need of longitudinal, practice & device-diverse and clinical validated data

Our Solutions

For Medical Devices AI R&D \
One-stop shop for your artificial intelligence (AI) training and FDA/CE regulatory data through subscription to Segmed high-quality database and regulatory-grade validation datasets.\
\
Learn More

For Clinical Data Management \
Data De-Identification\
\
Image Data Extraction\
\
Medical Imaging Data Exploration\
\
Learn More

For Healthcare Providers \
Your medical imaging data can drive groundbreaking innovation in healthcare.\
\
Learn More

Customers

Companies driving healthcare innovation with Real-World Imaging Data

Featured Cases

Transforming healthcare data into impact

From Concept to Clinical Practice: How Segmed Powered RadUnity’s Fast-Track to FDA Clearance

Driving AI-Powered Healthcare Innovation: How Segmed Helped NeuroCare.AI Achieve Success

Unlocking Value from Medical Data: Zwanger Pesiri Radiology’s Success with Segmed

Aidence Case Study: Key Insights & Outcomes from Segmed

Testimonials

“The ability to get data from multiple different manufacturers and practices in such a seamless manner with a very straightforward legal contract is the special sauce of working with Segmed. The ability to query on specific clinical indications and findings was more than I expected and definitely met our needs.”

Tim “Stick” Szczykutowicz, Ph.D., Founder @ RadUnity Corp.

"Segmed has been instrumental in our success at NeuroCare.AI. The high-quality, de-identified medical datasets have significantly accelerated our R&D and supported key performance testing for FDA approval, ensuring the highest standards of compliance and reliability. Professionalism and timely support make Segmed a trusted partner."

Junaid Kalia, MD, Founder and CEO @ SaveLife.AI

"Collaborating with Segmed has been highly valuable for our research in lung cancer AI. Their diverse, de-identified datasets allow us to efficiently and rigorously validate clinically reliable AI models at a scale that was previously out of reach. Segmed’s professionalism and commitment to the integrity of data make them a trusted partner as we advance robust, generalizable solutions for lung cancer care."

Firdaus Mohamed Hoesein, MD, Radiologist (Thoracic & Cardiac Imaging), Assistant Professor @ UMC Utrecht, Netherlands

Empowering Health

The Premier Authority: Diverse, High-Quality Medical Imaging Ecosystem

2,000+

Healthcare

partner sites

100,000,000+

Imaging studies

with diverse

patient coverage

35+

Cutting-edge

products FDA-cleared

using Segmed's data

50

States in the

USA have been sourced

5

Data from 5

continents

Let´s discuss how Segmed can be your medical imaging data provider

Contact Us

Create more equitable healthcare outcomes by leveraging the power of data.

Read More

Our Press Releases

Newsroom

Segmed Renews ISO/IEC 27001:2022 Certification, Strengthening Its Leadership in Secure Medical Data Innovation

Segmed Appoints David Gascoigne as CEO in Leadership Transition \
\
Co-Founder Dr. Martin Willemink moves to Chief Scientific Officer role; Dr. Yin Ho joins Board of Directors as part of Segmed’s leadership evolution

Segmed Unveils New Brand Identity and Introduces Openda, the Next Evolution for Its Insight Platform

This rebranding initiative reflects Segmed’s commitment to not only being the leading imaging data provider to the AI healthcare space, but also bringing medical imaging data to life sciences and biopharma.

Our Hub of Expert Content

Check out our latest news and updates

Resources

\
\
\
\
Blogs Insights and inspiration
\
\
\
\
Publications Expert knowledge
\
\
\
\
Events Join us: upcoming events and conferences
\
\
\
\
Webinars Engage and learn

Main

Home About Careers Contact

Technology

Publications & News

Legal & Regulatory

Chat Widget

网站信息

官网地址
https://segmed.ai/
域名
segmed.ai
收录路径
segmed